Science In (UK) Buy Hold or Sell Recommendation
| SIS Stock | 26.50 0.00 0.00% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Science in Sport is 'Strong Sell'. Macroaxis provides Science In buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SIS positions.
Check out Science In Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Science and provide practical buy, sell, or hold advice based on investors' constraints. Science in Sport. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Science |
Execute Science In Buy or Sell Advice
The Science recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Science in Sport. Macroaxis does not own or have any residual interests in Science in Sport or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Science In's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Science In Trading Alerts and Improvement Suggestions
| Science in Sport has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 62.67 M. Net Loss for the year was (11.28 M) with profit before overhead, payroll, taxes, and interest of 26.94 M. | |
| About 68.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Save up to 62 percent on gels, electrolyte and recovery drinks ahead of Black Friday - Runners World UK |
Science In Returns Distribution Density
The distribution of Science In's historical returns is an attempt to chart the uncertainty of Science In's future price movements. The chart of the probability distribution of Science In daily returns describes the distribution of returns around its average expected value. We use Science in Sport price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Science In returns is essential to provide solid investment advice for Science In.
| Mean Return | 0.07 | Value At Risk | -1.96 | Potential Upside | 2.04 | Standard Deviation | 1.45 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Science In historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Science In Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 961K | (833K) | (1.5M) | 1.8M | (126K) | (132.3K) | |
| Change In Cash | (2.6M) | 5.1M | (5.6M) | (3.9M) | 1.2M | 1.3M | |
| Free Cash Flow | (2.5M) | 1.0M | (6.7M) | (16.6M) | 1.1M | 1.2M | |
| Depreciation | 2.8M | 3.2M | 3.6M | 4.8M | 6.3M | 6.6M | |
| Other Non Cash Items | 5.7M | 47K | 112K | 757K | 2.7M | 2.8M | |
| Capital Expenditures | 2.4M | 2.1M | 6.5M | 8.0M | 2.1M | 2.2M | |
| Net Income | (5.6M) | (1.7M) | (6.8M) | (10.9M) | (11.3M) | (10.7M) | |
| End Period Cash Flow | 5.4M | 10.5M | 4.9M | 930K | 2.1M | 2.0M | |
| Change To Netincome | 1.7M | (319K) | 4.5M | 1.4M | 1.6M | 1.5M | |
| Investments | (2.4M) | (2.1M) | (6.5M) | (8.0M) | (2.1M) | (2.2M) |
Science In Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Science In or Food Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Science In's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Science stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.07 | |
β | Beta against Dow Jones | -0.11 | |
σ | Overall volatility | 1.43 | |
Ir | Information ratio | -0.02 |
Science In Volatility Alert
Science in Sport currently demonstrates below-average downside deviation. It has Information Ratio of -0.02 and Jensen Alpha of 0.07. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Science In's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Science In's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Science In Fundamentals Vs Peers
Comparing Science In's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Science In's direct or indirect competition across all of the common fundamentals between Science In and the related equities. This way, we can detect undervalued stocks with similar characteristics as Science In or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Science In's fundamental indicators could also be used in its relative valuation, which is a method of valuing Science In by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Science In to competition |
| Fundamentals | Science In | Peer Average |
| Return On Equity | -0.33 | -0.31 |
| Return On Asset | -0.0801 | -0.14 |
| Profit Margin | (0.19) % | (1.27) % |
| Operating Margin | (0.07) % | (5.51) % |
| Current Valuation | 72.58 M | 16.62 B |
| Shares Outstanding | 230.23 M | 571.82 M |
| Shares Owned By Insiders | 17.09 % | 10.09 % |
| Shares Owned By Institutions | 68.37 % | 39.21 % |
| Price To Book | 2.29 X | 9.51 X |
| Price To Sales | 1.13 X | 11.42 X |
| Revenue | 62.67 M | 9.43 B |
| Gross Profit | 26.94 M | 27.38 B |
| EBITDA | (3.7 M) | 3.9 B |
| Net Income | (11.28 M) | 570.98 M |
| Total Debt | 23.85 M | 5.32 B |
| Book Value Per Share | 0.15 X | 1.93 K |
| Cash Flow From Operations | 3.25 M | 971.22 M |
| Earnings Per Share | (0.06) X | 3.12 X |
| Target Price | 30.0 | |
| Number Of Employees | 330 | 18.84 K |
| Beta | 0.49 | -0.15 |
| Market Capitalization | 61.01 M | 19.03 B |
| Total Asset | 70.3 M | 29.47 B |
| Retained Earnings | (41.1 M) | 9.33 B |
| Working Capital | (5.27 M) | 1.48 B |
| Net Asset | 70.3 M |
Science In Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Science . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0151 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 26.3 | |||
| Day Typical Price | 26.37 | |||
| Market Facilitation Index | 0.4 | |||
| Price Action Indicator | 0.2 |
About Science In Buy or Sell Advice
When is the right time to buy or sell Science in Sport? Buying financial instruments such as Science Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Science In in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banks Thematic Idea Now
Banks
Large and small money and credit banks and credit services. The Banks theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Science Stock
Science In financial ratios help investors to determine whether Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Science with respect to the benefits of owning Science In security.